AEYE Health Announces Yonatan Raz-Fridman as Chief Business Officer to Propel AEYE-DS U.S. Market Expansion

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- AEYE Health, the leader in AI-powered retinal diagnostics, announces the appointment of Yonatan Raz-Fridman as its Chief Business Officer. Raz-Fridman is a visionary entrepreneur and technology executive, bringing extensive experience in founding and scaling technology companies. As the founder and former CEO of Supersocial, a leading metaverse studio, and the co-founder and former CEO of Kano Computing, an educational technology pioneer, he has a strong, proven track record of driving business growth and innovation.

In his role at AEYE Health, Raz-Fridman will lead growth strategy across channels, key accounts, forge strategic partnerships, and expand market reach to ensure AEYE's breakthrough technology reaches many millions of patients in the US and worldwide.

AEYE-DS is the fastest growing diabetic retinopathy screening technology in the US. It is the only FDA-cleared, fully autonomous AI that can screen patients anywhere using a portable device without the need for physician interpretation. The procedure takes a minute, closes the care gap for diabetic eye exam, and is reimbursable with CPT code 92229.

"We are thrilled to welcome Yonatan to AEYE Health's leadership team," said Zack Dvey-Aharon, Ph.D., Co-Founder & CEO of AEYE Health. "Yonatan brings entrepreneurial vision and a remarkable track record of building and scaling transformative companies. His leadership will be instrumental as we expand AEYE-DS across the United States, strengthen our strategic partnerships and channels, and advance our mission of leveraging cutting-edge AI to prevent blindness."

"I'm honored to join AEYE Health at such a pivotal time" said Raz-Fridman. "AEYE is transforming how diabetic retinopathy is diagnosed by bringing autonomous AI directly into point-of-care settings. I look forward to driving growth initiatives, scaling AEYE-DS adoption, and expanding the company's impact to reach more healthcare providers and patients, ultimately redefining the standard of care."

About AEYE Health

AEYE Health is a digital health company that provides fully autonomous, AI-based diagnostic screening solutions for retinal imaging with best-in-class clinical results and superior usability. The company aims to make diagnostic screening practical, accurate, and accessible. AEYE Health enables point-of-care screening for diabetic retinopathy to ensure that diabetics are regularly screened for diabetic retinopathy. AEYE-DS is the only FDA-cleared autonomous AI for diabetic retinopathy that requires just one image per eye and is the only approved AI for a portable camera. AEYE-DS is the fastest growing solution for diabetic retinopathy screening in the United States.

Media Contact
AEYE Health Press Team
[email protected]

SOURCE AEYE Health